Drugs affecting blood pressure variability: an update

Area of Science:

• Cardiology
• Hypertension Research
• Pharmacology

Background:

• Blood pressure variability (BPV) is an emerging risk factor for cardiovascular disease (CVD).
• Both short-term and long-term BPV independently contribute to organ damage, cardiovascular events, and mortality in hypertensive and diabetic patients.
• Reducing excessive BPV is a potential therapeutic target for cardiovascular prevention.

Purpose of the Study:

• To review current evidence on the impact of BPV on cardiovascular outcomes.
• To assess the efficacy of different antihypertensive drug classes in managing BPV.
• To highlight the need for further research on BPV control in cardiovascular disease.

Main Methods:

• Review of preclinical and clinical studies assessing drug effects on BPV.
• Analysis of prospective clinical trials comparing antihypertensive agents.
• Synthesis of current evidence on BPV and cardiovascular event prevention.

Main Results:

• Antihypertensive drug classes demonstrate varying abilities to control BPV, impacting clinical outcomes.
• Calcium channel blockers appear more effective than other antihypertensives in reducing short-term, mid-term, and long-term BPV.
• Evidence suggests BPV control is a significant factor in cardiovascular prevention.

Conclusions:

• BPV is a significant modifiable risk factor in cardiovascular disease.
• Targeting BPV reduction, particularly with calcium channel blockers, shows promise in cardiovascular prevention.
• Further clinical trials are needed to elucidate the full therapeutic significance of BPV control by antihypertensive drugs.